Cardiovascular Evaluation and Management of Dyspnea in Late Pregnancy

Immediate Assessment and Risk Stratification

• Perform an urgent comprehensive cardiovascular evaluation—including transthoracic echocardiography and a 12‑lead ECG—to rule out life‑threatening conditions such as mitral stenosis, pulmonary hypertension, peripartum cardiomyopathy, and pulmonary embolism in pregnant patients presenting with shortness of breath. 1
• Conduct a focused cardiovascular physical examination for signs of heart failure (elevated jugular venous pressure, pulmonary crackles, peripheral edema beyond physiologic pregnancy), murmurs suggestive of valvular disease, and indicators of pulmonary hypertension. 1

Diagnostic Workup

Echocardiography and ECG

• Urgent transthoracic echocardiography combined with ECG is the primary diagnostic tool for identifying structural and functional cardiac abnormalities in this population. 2
• The echocardiographic study must evaluate left‑ventricular systolic and diastolic function. 3
• Detailed assessment of valvular pathology—particularly mitral stenosis, which can be misattributed to normal pregnancy—should be performed. 1
• Identify any congenital or acquired structural cardiac abnormalities. 4

High‑Risk Cardiac Conditions to Exclude

• Pulmonary hypertension, mitral or aortic stenosis, and peripartum cardiomyopathy are the principal cardiac disorders that can present with dyspnea in the third trimester. Peripartum cardiomyopathy may manifest in the late third trimester. 3

Management Strategies

Referral and Multidisciplinary Care

• Immediately refer patients with identified cardiac disease to a specialist cardio‑obstetrics center for coordinated care involving cardiology, maternal‑fetal medicine, anesthesia, and neonatology. 2

Functional Classification

• Patients classified as NYHA class III or IV are considered high‑risk regardless of the underlying diagnosis, reflecting limited cardiovascular reserve. 1

Condition‑Specific Interventions

Mitral Stenosis

• Initiate beta‑blocker therapy for heart‑rate control and prescribe diuretics to relieve pulmonary congestion.
• In severe, symptomatic cases unresponsive to medical therapy, percutaneous balloon valvuloplasty can be safely performed during pregnancy. 4

Heart Failure / Peripartum Cardiomyopathy

• Maintain close maternal monitoring with serial echocardiography and symptom assessment throughout pregnancy.
• Consider BNP or NT‑proBNP measurement to aid risk stratification.
• Adjust heart‑failure regimen to include metoprolol (beta‑blocker), hydralazine, and nitrates; diuretics should be titrated to avoid fetal hypoperfusion.
• ACE inhibitors, ARBs, ARNIs, MRAs, and SGLT2 inhibitors are contraindicated in pregnancy. 5

Pulmonary Hypertension

• Recognize pulmonary hypertension as the highest‑mortality cardiac condition in pregnancy and provide intensive monitoring with early delivery planning. Multidisciplinary coordination is essential for timing and mode of delivery. 5

Surveillance, Follow‑Up, and Delivery Planning

• Schedule monthly or bimonthly cardiac evaluations—including repeat echocardiography—for patients with significant cardiac disease. 4
• Perform routine third‑trimester echocardiographic screening to reassess cardiac status before labor. 5
• Do not transfer a pregnant patient with cardiac disease solely for cesarean delivery; delivery should occur at a facility equipped with full cardiac and obstetric resources. 6
• Determine mode and timing of delivery through a multidisciplinary team based on maternal cardiac status and fetal well‑being; vaginal delivery is preferred unless obstetric indications dictate cesarean section. 4

General Principles

• Never attribute dyspnea in pregnancy to “normal physiologic changes” without first excluding serious cardiac or pulmonary pathology such as mitral stenosis or pulmonary hypertension. 1
• Do not discontinue essential cardiac or asthma medications during pregnancy; uncontrolled disease poses a greater risk to the fetus than the medications themselves. 5

Differential Diagnosis for Shortness of Breath at 30 Weeks Gestation

Immediate Assessment and Management

• The American College of Chest Physicians recommends obtaining oxygen saturation immediately and maintaining SpO2 >95% with supplemental oxygen as needed in patients with shortness of breath at 30 weeks gestation 7, 8
• The American Heart Association suggests positioning the patient in left lateral tilt to optimize venous return and cardiac output 9

Differential Diagnosis

• The American College of Cardiology notes that the differential diagnosis for dyspnea at 30 weeks gestation includes physiologic dyspnea of pregnancy, pulmonary embolism, peripartum cardiomyopathy, pre-existing or pregnancy-induced cardiac disease, asthma exacerbation, pneumonia, and rarely mediastinal masses or pneumothorax 10, 8
• The European Society of Cardiology states that pulmonary embolism remains the leading cause of pregnancy-related maternal death in developed countries, occurring in 1 per 1000 to 1 per 3000 deliveries 8

Diagnostic Approach

• The American Thoracic Society recommends performing bilateral lower extremity compression ultrasound first—if positive for DVT, this confirms venous thromboembolism and treatment can begin without further imaging 10
• The European Respiratory Society suggests that chest radiograph helps risk-stratify but normal results do not exclude PE 10, 11, 8
• The American College of Chest Physicians notes that D-dimer has poor specificity in pregnancy (15%) and inadequate sensitivity (73%) with negative likelihood ratio of 1.8, making it unreliable for excluding PE 10

Management

• The American College of Cardiology recommends anticoagulation with therapeutic-dose low molecular weight heparin for PE 10
• The European Society of Cardiology suggests beta blockers for rate control in mitral stenosis, diuretics for pulmonary congestion, and multidisciplinary cardio-obstetrics team management for cardiac disease 12
• The American Thoracic Society recommends continuing or intensifying controller medications, albuterol for acute symptoms, and budesonide as the preferred inhaled corticosteroid for asthma 7

Critical Pitfalls to Avoid

• The American College of Allergy, Asthma, and Immunology advises never discontinuing asthma medications during pregnancy—poorly controlled asthma causes more fetal harm than the medications 7
• The American College of Chest Physicians warns against relying on D-dimer to exclude PE in pregnancy—it has inadequate sensitivity and specificity 10
• The European Society of Cardiology cautions against withholding indicated imaging studies due to radiation concerns—the fetal radiation doses from chest radiograph and CT chest are well below harmful thresholds 11
• The American Heart Association recommends maintaining vigilance for 24-48 hours postpartum, as this period represents a second critical high-risk window for cardiorespiratory decompensation 7, 12